August 14, 2024 4:20 PM
ICMR and Panacea Biotec announces initiation of Phase 3 clinical trial for a dengue vaccine in India
The Indian Council of Medical Research (ICMR) and Panacea Biotec have initiated the first-ever Phase 3 clinical trial for a dengue vaccine in the country. The trial, which commenced on Wednesday at PGIMS Rohtak, will evaluate the efficacy of DengiAll...
